Back to today’s briefing

Story perspectives

AI Revolutionizes Genomic Diagnostics in US and Japan

9/26/2025

50 4 Full Breakdown

Summary

Story summary

AI and machine learning in next-generation sequencing data analysis enhance efficiency and accuracy in identifying genome variations.
Genomenon and Compass Bioinformatics aim to improve genomic diagnostics in the US and Japan through AI-driven analysis and comprehensive data.
In Japan, the InheriNext platform—used in over 40 rare disease institutes—will gain Genomenon's Mastermind FLEX Data to improve variant interpretation and patient outcomes.

1 of 1

Story summary

AI and machine learning in next-generation sequencing data analysis enhance efficiency and accuracy in identifying genome variations.
Genomenon and Compass Bioinformatics aim to improve genomic diagnostics in the US and Japan through AI-driven analysis and comprehensive data.
In Japan, the InheriNext platform—used in over 40 rare disease institutes—will gain Genomenon's Mastermind FLEX Data to improve variant interpretation and patient outcomes.